| Anti-inflammatory and anti-oxidant activities of olmesartan medoxomil ameliorate experimental colitis in rats MM Nagib, MG Tadros, MI ELSayed, AE Khalifa Toxicology and applied pharmacology 271 (1), 106-113, 2013 | 106 | 2013 |
| Neuroinflammatory mediators in acquired epilepsy: an update Y Chen, MM Nagib, N Yasmen, MN Sluter, TL Littlejohn, Y Yu, J Jiang Inflammation Research 72 (4), 683-701, 2023 | 35 | 2023 |
| Targeting prostaglandin receptor EP2 for adjunctive treatment of status epilepticus MM Nagib, Y Yu, J Jiang Pharmacology & therapeutics 209, 107504, 2020 | 30 | 2020 |
| Molecular mechanisms of neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: Impact on Sirt1/NRF2 signaling pathways. MM Nagib, MG Tadros, HAA Al-Khalek, RM Rahmo, NA Sabri, AE Khalifa, ... Neurotoxicology 68, 47-65, 2018 | 29 | 2018 |
| Ameliorative effects of α-tocopherol and/or coenzyme Q10 on phenytoin-induced cognitive impairment in rats: role of VEGF and BDNF-TrkB-CREB pathway MM Nagib, MG Tadros, RM Rahmo, NA Sabri, AE Khalifa, SI Masoud Neurotoxicity Research 35, 451-462, 2019 | 22 | 2019 |
| Inhibition of TRPC3 channels by a novel pyrazole compound confers antiseizure effects MM Nagib, S Zhang, N Yasmen, L Li, R Hou, Y Yu, VK Boda, Z Wu, W Li, ... Epilepsia 63 (4), 1003-1015, 2022 | 11 | 2022 |
| Retraction notice to" Molecular mechanisms of neuroprotective effect of adjuvant therapy with phenytoin in pentylenetetrazole-induced seizures: Impact on Sirt1/NRF2 signaling … MM Nagib, MG Tadros, HA Abd Al-khalek, RM Rahmo, NA Sabri, ... Neurotoxicology 97, 157, 2023 | | 2023 |
